Science, Religion, and Philosophy News @
Jan 31 2017
Danish Drugmaker Novo Nordisk Bets $145 Million On Post-Brexit UK Science
Novo Nordisk, the world's top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain, undeterred by Brexit.